Medtronic Announces New Kyphoplasty Platform
This article was originally published in The Gray Sheet
Executive Summary
The firm says the new system will give physicians more options to treat patients with a varying severity of spinal injury.
You may also be interested in...
Medtronic Goes Trolling? Kyphon Patents Are Basis Of New Suits, But Not From Medtronic
Recently incorporated Orthophoenix, which shares the same Dallas address as IPNav, a company that provides “full-service patent monetization,” is suing six device firms for infringement of the Medtronic kyphoplasty patents it recently acquired.
Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
Medtronic is aiming to expand the breadth of its spinal offerings and, in particular, reach a relatively untapped older patient population with its $3.9 billion acquisition of Kyphon, announced July 27 (see chart: "1Medtronic-Kyphon Deal Basics")
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.